BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27819744)

  • 1. Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.
    Liu HX; Li J; Ye BG
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in DNA repair genes
    Alsagaby S; Ahmed AA; Rasheed Z; Althwab SA; Aljohani ASM; Alhumaydhi FA; Alhomaidan HT; Alkhamiss AS; Alkhowailed M; Alaqeel A; Alblihed MA; Alrehaili J; Fernández N; Abdulmonem WA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):530-554. PubMed ID: 35319340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.
    Kiyohara C; Horiuchi T; Takayama K; Nakanishi Y
    J Thorac Oncol; 2012 Jun; 7(6):954-62. PubMed ID: 22525558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer.
    Liu JY; Liu QM; Li LR
    Genet Mol Res; 2015 Aug; 14(3):10331-7. PubMed ID: 26345972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
    Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
    Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
    Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
    J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
    Wang N; Wu Y; Zhou X; Wu Y
    Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of combined OGG1, CYP1A1 and GSTP1 gene variants and risk of lung cancer of male Iraqi waterpipe tobacco smokers.
    Kudhair BK; Alabid NN; Zayed KS; Lafta IJ; Taheri-Kafrani A
    Mol Biol Rep; 2020 Jul; 47(7):5155-5163. PubMed ID: 32577993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
    Li F; Wang J; Chen M
    Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.
    Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):258-65. PubMed ID: 16492913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.
    Li W; Li K; Zhao L; Zou H
    Gene; 2014 Apr; 538(2):361-5. PubMed ID: 24368330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.
    Khlifi R; Olmedo P; Gil F; Hammami B; Hamza-Chaffai A; Rebai A
    J Appl Genet; 2017 May; 58(2):221-229. PubMed ID: 27838878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
    Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
    Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.
    He L; Gao L; Shi Z; Li Y; Zhu L; Li S; Zhang P; Zheng G; Ren Q; Li Y; Hu B; Feng F
    PLoS One; 2015; 10(3):e0119481. PubMed ID: 25798582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.